BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22569435)

  • 1. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
    Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
    Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
    Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.
    Malekshahi Moghadam A; Saedisomeolia A; Djalali M; Djazayery A; Pooya S; Sojoudi F
    Singapore Med J; 2012 Sep; 53(9):615-9. PubMed ID: 23023905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
    Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ann Nutr Metab; 2011; 58(3):197-202. PubMed ID: 21757893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
    Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
    Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
    Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T; Schmidt EB; Christensen JH
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.
    Peng YS; Chiu YL; Chen HY; Yang JY; Lai CF; Hsu SP; Pai MF
    Nephrology (Carlton); 2010 Oct; 15(7):692-9. PubMed ID: 21040164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
    Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
    Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
    Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
    J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of elevated gingival crevicular fluid tumor necrosis factor-alpha and interleukin-8 levels in chronic hemodialysis patients with periodontal disease.
    Dağ A; Firat ET; Kadiroğlu AK; Kale E; Yilmaz ME
    J Periodontal Res; 2010 Aug; 45(4):445-50. PubMed ID: 20337890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.
    Hassan KS; Hassan SK; Hijazi EG; Khazim KO
    Ren Fail; 2010; 32(9):1031-5. PubMed ID: 20863205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
    Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B
    Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.